Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_assertion type Assertion NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_head.
- NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_assertion description "[According to the microarray profiles, PTP4A3/PRL-3 was upregulated in patients with poorly differentiated disease compared to patients with well-differentiated disease with hepatic backgrounds associated with hepatitis B or C. Validation analysis showed that the PTP4A3/PRL-3 mRNA and protein levels were significantly associated with poor differentiation (P<0.0001), high serum ?-fetoprotein (P<0.01), high serum protein induced by vitamin K absence/antagonist-II (PIVKA-II), and hepatic vascular invasion (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_provenance.
- NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_assertion evidence source_evidence_literature NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_provenance.
- NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_assertion SIO_000772 23064776 NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_provenance.
- NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_assertion wasDerivedFrom befree-2016 NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_provenance.
- NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_assertion wasGeneratedBy ECO_0000203 NP1020862.RAJ2FIU3NEYuPtDbMKDpGSt5Nn0F9b8G2w3rUtcHDqVFY130_provenance.